TW200416045A - Oil-in-water emulsion composition and manufacturing method thereof - Google Patents

Oil-in-water emulsion composition and manufacturing method thereof Download PDF

Info

Publication number
TW200416045A
TW200416045A TW92126607A TW92126607A TW200416045A TW 200416045 A TW200416045 A TW 200416045A TW 92126607 A TW92126607 A TW 92126607A TW 92126607 A TW92126607 A TW 92126607A TW 200416045 A TW200416045 A TW 200416045A
Authority
TW
Taiwan
Prior art keywords
oil
water
supplement
formula
straight
Prior art date
Application number
TW92126607A
Other languages
Chinese (zh)
Other versions
TWI342220B (en
Inventor
Yukihisa Hashimoto
Chiaki Sone
Atsuyuki Kiba
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of TW200416045A publication Critical patent/TW200416045A/en
Application granted granted Critical
Publication of TWI342220B publication Critical patent/TWI342220B/zh

Links

Landscapes

  • Cosmetics (AREA)

Abstract

The purpose of the present invention is to provide a water in oil (W/O) emulsion composition, which can stably emulsify an oil phase of the amphipathic lipid such as ceramide at a low concentration of surfactant and has excellent feeling in use, and a manufacturing method thereof. In order to achieve the above-mentioned purpose, the invented W/O emulsion composition comprises: (A) at least one kind of specified quaternary ammonium salt cation type surfactants, (B) an amphipathic lipid, (C) at least one of bivalent and trivalent alcohols, and (D) water, in which the cation type surfactant (A) is at a concentration of 0.1 to 1 mass %. Moreover, the manufacturing method of the invented W/O emulsion composition comprises mixing (A) at least one kind of specified quaternary ammonium salt cation type surfactants and (C) at least one of bivalent and trivalent alcohols, adding (B) an oil phase of an amphipathic lipid, and then adding (D) water medium.

Description

200416045 玖、發明說明: 【發明所屬之技術領域】 本發明係關於一種水中油型乳化組成物及其製 法,該水中油型乳化組成物含有兩親媒性脂質,即使 濃度的界面活性劑下該兩親媒性脂質的乳化安定性 好,且使用感優異的。 【先前技術】 為了賦予皮膚、黏膜、毛髮等濕潤性與柔軟性,角 中的水分是重要的,此乃眾所周知之情事。另一方面 角質層係作為生物體的屏障層而發揮皮膚(角質層)的 與水分蒸發抑制的作用,此亦為眾所周知之情事。 近年來,存在於皮膚角質層之細胞間脂質對於角質 的保持與屏障作用有重大的關連之事實逐漸被揭示出 因此,為提高保濕效果,不斷提案出調配有存在於皮 質層之細胞間脂質的主成份之神經醯胺(c e r a m i d e )與 之類似物質等之兩親媒性脂質的化妝材料。然而,由 等兩親媒性脂質對水之溶解性低,未達相當的高溫之 下係保持著固態狀,因而,尤其是欲安定地配製成水 型乳化組成物時,必須使用大量的界面活性劑。而相>5 通常,化妝材料中的界面活性劑(例如非離子型界面活 的使用量,則希望儘可能地減少。 另一方面,人的正常皮膚係被弱酸性的皮脂皮膜所 著,通常,對於來自外部的鹼性物質之接觸,會自然 制肌膚的p Η。例如,將皮膚表皮以脂肪酸皂洗淨會成 312/發明說明書(補件)/92-12/92126607 造方 於低 亦良 質層 ,此 保水 水分 來。 膚角 其等 於此 情況 中油 k地, 性劑) 覆蓋 地控 為弱 5 200416045 鹼性,但於正常的皮膚中,經由來自皮脂的游離脂肪酸進 行著自然中和。亦即,適用於皮膚之外用劑或化妝材料, 儘可能地作成為與人的正常皮膚接近的p Η之弱酸性,對於 皮膚可有良好的影響,尤其對皮膚敏感的人更為需要。因 而,於弱酸性的化妝材料中,以較少的界面活性劑來安定 地調配細胞間脂質成分的技術正受到檢討中。 於曰本專利特開 2 0 0 2 - 1 1 4 6 3 1 號公報中揭示有一種方 法,其係將神經醯胺類等之兩親媒性脂質溶解於融點未滿 3 0 °C的液體油中所成之油份、與水性介質,用聚甘油脂肪 酸酯進行乳化,藉以製得安定的乳化組成物。然而,於此 方法中,若欲製得安定的乳化物,須要與兩親媒性脂質等 量的程度之大量的聚甘油脂肪酸酯,又,欲製得弱酸性的 乳化物,必須添加有機酸等酸性物質來調整p Η。 又,於曰本專利特開平 4 - 1 9 3 8 1 4號公報中,曾嘗試併 用非離子型界面活性劑與陰離子型界面活性劑以使兩親媒 性脂質安定化。然而,於此組合中所用的界面活性劑的量 亦多,且於pH為6以下的酸性範圍中,陰離子型界面活性 劑會有難以發揮作為乳化劑的作用之傾向。 因而,本發明之目的在於提供可以低濃度的界面活性劑 安定地乳化含有通常難以調配到水性介質中之神經醯胺等 之兩親媒性脂質的油相,且使用感優異的水中油型乳化組 成物,及其製造方法。 【發明内容】 本發明者發現,藉由併用特定的陽離子型界面活性劑與 6 312/發明說明書(補件)/92-12/92126607 200416045 2價或3價的醇,可以低濃度的界面活性劑安定地乳化兩 親媒性脂質,並可得到使用感優異的水中油型乳化組成物。 亦即,本發明提供一種水中油型乳化組成物,其特徵在 於含有·· (A)以下述通式(1)所表示之4級銨鹽型陽離子型 界面活性劑之至少1種、(B)兩親媒性脂質、(C) 2價及3 價的醇之至少1種、及(D)水;前述陽離子型界面活性劑(A ) 的含有量為0 . 1〜1質量%。200416045 发明 Description of the invention: [Technical field to which the invention belongs] The present invention relates to an oil-in-water emulsion composition and a method for preparing the same. The oil-in-water emulsion composition contains amphiphilic lipids, even if the concentration of the surfactant is Amphiphilic lipids have good emulsification stability and excellent use feeling. [Prior art] In order to impart moistness and softness to the skin, mucous membranes, hair, etc., moisture in the horns is important, and this is well known. On the other hand, it is a well-known fact that the stratum corneum acts as a barrier layer of the living body and suppresses the evaporation of water from the skin (cuticle). In recent years, the fact that intercellular lipids existing in the stratum corneum of the skin has a significant correlation with the maintenance of keratin and the barrier effect has gradually been revealed. Therefore, in order to improve the moisturizing effect, it is continuously proposed to adjust The main component is ceramide and similar materials such as amphipathic lipids. However, since the solubility of amphiphilic lipids in water is low and the solid state is maintained below a considerable temperature, especially when it is to be stably formulated into an aqueous emulsion composition, a large amount of Surfactant. Phase> 5 Generally, the amount of surfactant (such as non-ionic surfactant) in cosmetic materials is expected to be reduced as much as possible. On the other hand, the normal skin of a person is covered by a weakly acidic sebum film. Generally, the contact of alkaline substances from the outside will naturally make skin pΗ. For example, washing the skin epidermis with fatty acid soap will become 312 / Invention Manual (Supplement) / 92-12 / 92126607 It is also a good layer, which retains water. The skin angle is equal to the oil in this case. The coverage is controlled to be weak. 5 200416045 Alkaline, but in normal skin, it is naturally neutralized by free fatty acids from sebum. . That is, it is suitable for external skin preparations or cosmetic materials, and as weak as possible, which is close to the normal skin of humans, it can have a good effect on the skin, especially for people who are sensitive to the skin. Therefore, in weakly acidic cosmetic materials, techniques for stably formulating intercellular lipid components with fewer surfactants are under review. A method is disclosed in Japanese Patent Application Laid-Open No. 2000-2-1 1 4 6 3 1 by dissolving amphipathic lipids such as neural amines in a melting point below 30 ° C. The oil content formed in the liquid oil and the aqueous medium are emulsified with a polyglycerol fatty acid ester to obtain a stable emulsified composition. However, in this method, if a stable emulsion is to be obtained, a large amount of polyglycerin fatty acid ester is required in an amount equivalent to that of the amphiphilic lipid, and if a weakly acidic emulsion is to be obtained, organic must be added. Acids such as acids to adjust p Η. Further, in Japanese Patent Application Laid-Open No. 4-119 3 8 14, attempts have been made to stabilize amphiphilic lipids by using a non-ionic surfactant and an anionic surfactant in combination. However, the amount of the surfactant used in this combination is also large, and in the acidic range of pH 6 or lower, the anionic surfactant tends to have difficulty in functioning as an emulsifier. Therefore, an object of the present invention is to provide a low-concentration surfactant that can stably emulsify an oil phase containing amphiphilic lipids such as ceramide, which is difficult to be formulated into an aqueous medium, and has excellent usability. Composition, and its manufacturing method. [Summary of the Invention] The inventors have discovered that by using a specific cationic surfactant in combination with 6 312 / Invention Specification (Supplement) / 92-12 / 92126607 200416045 a divalent or trivalent alcohol, a low concentration of interfacial activity can be achieved. The agent stably emulsifies amphiphilic lipids, and an oil-in-water emulsified composition having excellent usability can be obtained. That is, the present invention provides an oil-in-water emulsion composition, comprising: (A) at least one of a fourth-order ammonium salt type cationic surfactant represented by the following general formula (1), (B ) Amphiphilic lipid, (C) at least one of divalent and trivalent alcohols, and (D) water; the content of the aforementioned cationic surfactant (A) is 0.1 to 1% by mass.

再者,本發明提供一種水中油型乳化組成物之製造方 法,其特徵在於,將(A)以下述通式(1 )所表示之4級銨鹽 型陽離子型界面活性劑之至少1種、與(C) 2價及3價的醇 之至少 1 種混合之後,添加入(B )含有兩親媒性脂質的油 相,然後再添加水性介質。Furthermore, the present invention provides a method for producing an oil-in-water emulsified composition, characterized in that (A) at least one of a fourth-order ammonium salt type cationic surfactant represented by the following general formula (1), After mixing with (C) at least one of divalent and trivalent alcohols, (B) adding an oil phase containing amphiphilic lipids, and then adding an aqueous medium.

(式中,R 1及R2為分別獨立之碳數1 6〜2 2之直鏈或分枝 鏈的飽和或不飽和的烴基,R3及R4為分別獨立之碳數1〜3 之烷基,X#為形成鹽之陰離子。) 【實施方式】 本說明書中所引用之文獻的内容,經由參照而作為構成 本說明書的一部份者。 本發明之水中油型乳化組成物,係將(B )含有兩親媒性 脂質的油相與(C)含有選自2價及3價的醇之醇類(以下, 稱為醇類(C ))之水性連續相,藉由(A )以上述通式(1 )所表 7(In the formula, R 1 and R 2 are independent saturated or unsaturated hydrocarbon groups of straight or branched carbon numbers of 16 to 22, and R 3 and R 4 are independent alkyl groups of 1 to 3 carbons. X # is a salt-forming anion.) [Embodiment] The contents of documents cited in this specification are a part of this specification by reference. The oil-in-water emulsion composition of the present invention comprises (B) an oil phase containing an amphiphilic lipid and (C) an alcohol (hereinafter, referred to as an alcohol (C) containing an alcohol selected from a divalent and a trivalent alcohol. )) In the aqueous continuous phase, as shown in Table 7 by (A) by the above general formula (1)

312/發明說明書(補件)/92-12/92126607 200416045 示之4級銨鹽型陽離子型界面活性劑(以下,稱 界面活性劑(A ))進行乳化所成之乳化組成物。 本發明之乳化組成物中之陽離子型界面活个 親媒性脂質(B ),係於含有醇類(C )的水性介質 成液晶(或α -膠體構造),以形成增黏構造體。 構造體顯示出黏性行為,對於油滴的合-(c r e a m i n g )可成為安定的狀態。藉由這樣的組 離子型界面活性劑(A)為低濃度,亦可形成安定 構造,因此,界面活性劑的使用量可減少。此 黏構造體具有光學異向性,可用偏光顯微鏡等 又,由於本發明之乳化組成物顯示 (thixotropy),上述增黏構造體雖於靜置狀態 定的液晶構造’但於塗佈時則容易破壞液晶構 均一地延展於塗佈部上,故有清爽、清新的使 再者,本發明之乳化組成物為弱酸性,就對 性與使用感的觀點考量屬較佳情況。具體而言 以上且不滿7為佳。 於本發明中,藉由作成上述成分(A)、(B)、 組合,即使未經由pH調整劑之添加來將pH調 亦可得到弱酸性的乳化組成物。 本發明中所使用之陽離子型界面活性劑(A ) 有取代基之於一分子内具有2個長鏈的烴基之 造的陽離子型界面活性劑。作為陽離子型界面 尤其就對皮膚之親和性的觀點考量,可使用由一 312/發明說明書(補件)/92-12/92126607 為陽離子型 :劑(A )與兩 中會合而形 所得之增黏 •、乳霜化 合,即使陽 性兩的液晶 處,由於增 確認。 有搖溶性 下保持著安 造,可薄且 用感。 皮膚的刺激 ,以p Η為4 (C )及(D )的 整為酸性, ,為亦可具 4級銨鹽構 舌性劑(A ), _述通式(1 ) 8 200416045 所表示者。312 / Invention Specification (Supplement) / 92-12 / 92126607 200416045 The emulsified composition formed by emulsifying the fourth-stage ammonium salt type cationic surfactant (hereinafter, referred to as surfactant (A)). The cationic interfacial active lipid (B) in the emulsified composition of the present invention is formed into an liquid crystal (or an α-colloid structure) in an aqueous medium containing an alcohol (C) to form a thickened structure. The structure exhibits a viscous behavior, and can be stabilized with respect to the combination of oil droplets (c r e a m i n g). With such a low concentration of the ionic surfactant (A), a stable structure can also be formed. Therefore, the amount of the surfactant used can be reduced. This viscous structure has optical anisotropy, and a polarizing microscope can be used. Because the emulsified composition of the present invention is thixotropy, the above-mentioned tackified structure is a liquid crystal structure that is fixed in a static state, but it is easy to apply it. The liquid crystal structure is destroyed and spreads uniformly on the coating part, so it is refreshing and refreshing. Furthermore, the emulsified composition of the present invention is weakly acidic, and it is preferable to consider the viewpoint of sex and usability. Specifically, the above and less than 7 are preferable. In the present invention, by preparing the above-mentioned components (A), (B), and a combination, a weakly acidic emulsified composition can be obtained even if the pH is not adjusted by the addition of a pH adjuster. The cationic surfactant (A) used in the present invention is a cationic surfactant having a substituent and having two long-chain hydrocarbon groups in one molecule. As a cationic interface, especially from the viewpoint of skin affinity, an increase in the form of a cationic type: Agent 312 / Invention Specification (Supplement) / 92-12 / 92126607 can be used. Sticky, creamy combination, even if the positive two liquid crystal parts, due to increase confirmation. It keeps its manufacture with shake-solubility, can be thin and feels good. For skin irritation, p Η is 4 (C) and (D), which is acidic, and is a tongue-forming agent (A) that can also have a level 4 ammonium salt. _ Formula (1) 8 200416045 .

X— 式(1) (式中,R 1及R2為分別獨立之碳數1 6〜2 2之直鏈或分枝鏈 的飽和或不飽和的烴基,R3及R4為分別獨立之碳數1〜3之 烷基,X ^為形成鹽之陰離子。) 作為式(1)中之烴基R1及R2,可列舉出烷基或鏈烯基。 作為形成鹽之陰離子,可舉出:iS素離子、磷酸離子、醋 酸離子、乳酸離子、單烷基硫酸離子等。 作為陽離子型界面活性劑的具體例,可舉出:氯化二錄 蠟基二曱基銨、氯化二硬脂基二甲基銨、氯化二芳烷基二 甲基銨、氯化二山榆基(dibehenyl)二曱基銨等。其中,氯 化二鯨蠟基二甲基銨、氣化二硬脂基二甲基銨有市售品可 取得,可舉出:Varisoft TA-432CG、 Varisoft TA-100 (Goldschmidt 公司製),Qua;rtamin D-86P(Kao 公司製)等。 此等界面活性劑之中,由具有對皮膚之親和力考量,以 氣化二鯨蠟基二甲基銨、氯化二硬脂基二甲基銨等為佳。 陽離子型界面活性劑(A )的含有量,自與後述之兩親媒 性脂質(B )及醇類(C )共同形成較佳的液晶構造體的觀點考 量,在水中油型乳化组成物的總組成中宜為0 . 1〜1質量°/〇, 而以0 · 5〜1質量%更佳。 本發明中所謂的兩親媒性脂質(B ),係指於分子内同時 具有親水部與疏水部,且於2 5 °C時為固體的物質。作為兩 312/發明說明書(補件)/92-12/92126607 9 200416045 親媒性脂質(B),可舉出例如:膽固醇、膽固醇酯、膽 硫酸酯等之膽固醇類;硬脂酸、棕櫚酸等之高級脂肪 魚京虫鼠醇、硬月旨醇、山榆醇、鯊肝醇(b a t y 1 a 1 c h ο 1 )、 醇(c h i m y 1 a 1 c o h o 1 )等之高級醇及其相關的化合物; 脂肪酸酯類等。 又,作為尤其對於皮膚的屏障作用與保濕作用優異 具有優異的肌膚粗糙之改善效果的兩親媒性脂質,可 以下述通式(2 )〜(4 )所表示之醯胺化合物: 固醇 酸; 鮫肝 甘油 、並 舉出 R11X— Formula (1) (where R 1 and R 2 are independent saturated or unsaturated hydrocarbon groups of straight or branched carbon number 1 6 to 2 2; R 3 and R 4 are independent carbon numbers 1 An alkyl group of ˜3, X ^ is a salt-forming anion.) Examples of the hydrocarbon groups R1 and R2 in the formula (1) include an alkyl group and an alkenyl group. Examples of the salt-forming anion include an iS element ion, a phosphate ion, an acetic acid ion, a lactic acid ion, and a monoalkyl sulfate ion. Specific examples of the cationic surfactant include diluxyl diammonium chloride, distearyl dimethyl ammonium chloride, diaralkyl dimethyl ammonium chloride, and dichloro chloride. Dimuhenyl (dibehenyl) and other ammonium. Among them, commercially available products of dicetyl dimethyl ammonium chloride and vaporized distearyl dimethyl ammonium include Varisoft TA-432CG, Varisoft TA-100 (manufactured by Goldschmidt), Qua rtamin D-86P (manufactured by Kao). Among these surfactants, from the viewpoint of their affinity to the skin, it is preferred to vaporize dicetyldimethylammonium, distearyldimethylammonium chloride, and the like. The content of the cationic surfactant (A) is considered from the viewpoint of forming a better liquid crystal structure together with the amphiphilic lipid (B) and alcohol (C) described later. The total composition is preferably 0.1 to 1 mass ° / 〇, and more preferably 0.5 to 1 mass%. The so-called amphiphilic lipid (B) in the present invention refers to a substance having both a hydrophilic portion and a hydrophobic portion in the molecule and being solid at 25 ° C. Examples of the two 312 / Invention (Supplement) / 92-12 / 92126607 9 200416045 The compatibilizing lipids (B) include, for example, cholesterols such as cholesterol, cholesterol esters, and bile sulfate; stearic acid and palmitic acid High-grade fatty fish such as benzyl alcohol, hard moon alcohol, behenyl alcohol, shark liver alcohol (baty 1 a 1 ch ο 1), alcohol (chimy 1 a 1 coho 1), and other higher alcohols and related compounds ; Fatty acid esters and so on. In addition, as amphiphilic lipids that are excellent in skin barrier effect and moisturizing effect and have excellent skin roughness improvement effects, amido compounds represented by the following general formulae (2) to (4): sterol acid ; 鲛 liver glycerin, and cited R11

一 C——NHII I 〇 HC—CH2-〇HI R12 — CH-OH 式(2) (式中,R 11為亦可以1個以上的羥基取代之碳數8〜5 0 鏈或分枝鏈的飽和或不飽和的烴基,或以 R13-C00-R 表示的基,R 13為碳數8〜3 0的直鏈或分枝鏈的飽和或 和的烴基,R14為亦可以1個以上的羥基取代之碳數 的直鏈或分枝鏈的飽和或不飽和的二價烴基。R 12為亦 1個以上的羥基取代之碳數8〜5 0的直鏈或分枝鏈的飽 的直 4 -所 不飽 8〜40 可以 和或 不飽和的烴基 R17^ I R15-C—N一CH2 0 HC—Y R16—CH2 式(3) (式中 為亦可以1個以上的羥基取代之碳數7〜2 5 鏈或分枝鏈的飽和或不飽和的烴基,R16為亦可以1個 的羥基取代之碳數 8〜2 6的直鏈或分枝鏈的飽和或不 的直 以上 飽和 312/發明說明書(補件)/92-12/92126607 10 200416045 的烴基或烷氧基。R 17為氫原子、2 -羥乙基或 2,3 -二羥丙 基。Y為氫原子或羥基。) Η ο Ο Μ R18—Ο—R19—Ν——C——R20—C——N——R19—O——R18 式(4 ) (式中,R 18為各自獨立的亦可以羥基及/或烷氧基取代之碳 數 1〜2 2 的直鏈或分枝鏈的烴基,R 19為各自獨立的碳數 1〜1 2的直鏈或分枝鏈的二價烴基,R ^為碳數1〜4 2的直鏈 或分枝鏈的二價烴基。) 於通式(2 )中,較佳情況為:R 11為亦可以1個以上的羥基 取代之碳數 8〜3 0 的直鏈或分枝鏈的飽和或不飽和的烴 基,或以R13-COO-R14 -所表示的基。此處,R13以碳數8〜30 的直鏈或分枝鏈的飽和或不飽和的烴基為佳,R 14以亦可由 1個以上的經基取代之碳數8〜3 0的直鏈或分枝鏈的飽和或 不飽和的二價烴基為佳。R 12以亦可由1個以上的羥基取代 之碳數 8〜3 0 的直鏈或分枝鏈的飽和或不飽和的烴基為 佳。尤其,以 R 11及 R 13為碳數 8〜3 0的直鏈烷基,且 R 14 為碳數8〜3 0的直鏈伸烷基為佳。 作為以通式(2 )所表示之醯胺化合物,周知之較佳者為 Robson K . J . e t a 1. 、 J. Lipid Res. , 35, 2060(1994),與 Wertz P.W. et al. 、J. Lipid Res·,24, 759(1983)等中所 記載之型式1〜7的神經醯胺。此等可自動植物萃取及經由 反應修飾,或藉由完全合成而製造。又,作為式(2 )所表示 之醯胺化合物的市售品,可舉出··神經醯胺 I I I、神經醯 11 312/發明說明書(補件)/92-12/92126607 200416045 胺 I I I B、神經醯胺 I II A、神經醯胺 I V、f i t細胞間脂質 I (以上為 D E G U S S A 公司製)、神經醯胺 I I ( S e d e r m a公司 製)、神經醯胺T I C - 0 0 1 (高砂香料公司製)等。 於通式(3 )中,R 15為亦可由1個以上的羥基取代之碳數 1 4〜2 2 的直鏈或分枝鏈的飽和或不飽和的烴基為佳,尤以 直鏈烷基更佳。其中,以五癸基、三羥基五癸基為更佳。 R |6以碳數8〜2 4的直鏈的烷基或烷氧基為佳。其中,尤 以壬基、六癸氧基為更佳。 有關R 16與R 17的組合,於R 17為氫原子或2 -羥乙基時, R16以直鏈的烷氧基為佳,而於R17為2, 3 -二羥丙基時,R11 以直鏈的烷基為佳。 再者,有關Y與R17的組合,於R17為氫原子或2 -羥乙基 時,Y以羥基為佳,而於R17為2,3 -二羥丙基時,Y以氫原 子為佳。 作為以通式(3 )所表示之醯胺化合物,具體而言,可舉 出以下述所示之式(5)、(6)及(7)所表示之化合物。-C—NHII I 〇HC—CH2-〇HI R12 — CH-OH Formula (2) (wherein R 11 is a carbon number of 8 to 50, which may be substituted by one or more hydroxyl groups. Saturated or unsaturated hydrocarbon group, or a group represented by R13-C00-R, R 13 is a saturated or sum hydrocarbon group of a straight or branched chain having 8 to 30 carbon atoms, and R14 is one or more hydroxyl groups. Substituted straight or branched carbon chain saturated or unsaturated divalent hydrocarbon group. R 12 is a straight or branched straight chain with a carbon number of 8 to 50 that is substituted by one or more hydroxyl groups. -Unsaturated 8 to 40 can be unsaturated or unsaturated hydrocarbon group R17 ^ I R15-C-N-CH2 0 HC-Y R16-CH2 Formula (3) (where the number of carbons that can also be substituted by more than one hydroxyl group 7 ~ 2 5 chain or branched saturated or unsaturated hydrocarbon group, R16 is a saturated or non-saturated straight or branched straight or branched chain with carbon number 8 ~ 2 6 which can also be substituted by 1 hydroxyl group 312 / Description of the Invention (Supplement) / 92-12 / 92126607 10 200416045. Hydrocarbyl or alkoxy. R 17 is a hydrogen atom, 2-hydroxyethyl or 2,3-dihydroxypropyl. Y is a hydrogen atom or a hydroxyl group.) Η ο Ο Μ R18—〇—R19—Ν— —C——R20—C——N——R19—O——R18 Formula (4) (where, R 18 is each independently and can be substituted by a hydroxyl group and / or an alkoxy group with 1 to 2 2 carbon atoms. A straight or branched hydrocarbon group, R 19 is an independent, straight or branched chain divalent hydrocarbon group having 1 to 12 carbon atoms, and R ^ is a straight or branched chain carbon group of 1 to 4 carbon atoms. Divalent hydrocarbon group.) In the general formula (2), preferably: R 11 is a straight or branched saturated or unsaturated hydrocarbon group having 8 to 30 carbon atoms, which may be substituted by one or more hydroxyl groups. , Or a group represented by R13-COO-R14-. Here, R13 is preferably a saturated or unsaturated hydrocarbon group having a straight or branched chain of 8 to 30 carbon atoms, and R 14 may be composed of one or more A linear or branched saturated or unsaturated divalent hydrocarbon group having 8 to 30 carbon atoms substituted by a group is preferred. R 12 is a straight chain having 8 to 30 carbon atoms which may be substituted by one or more hydroxyl groups. Or branched chain saturated or unsaturated hydrocarbon groups are preferred. In particular, R 11 and R 13 are straight-chain alkyl groups having 8 to 30 carbon atoms, and R 14 is a straight-chain alkylene group having 8 to 30 carbon atoms. It is preferred that it is a sulfonamide compound represented by the general formula (2) The best known is Robson K. J. eta 1., J. Lipid Res., 35, 2060 (1994), and Wertz PW et al., J. Lipid Res., 24, 759 (1983), etc. Neuraminamine of the described types 1 to 7. These can be extracted automatically by plants and modified by reaction, or produced by complete synthesis. In addition, as a commercially available product of the amidine compound represented by the formula (2), ... neuramin III, nerve salamander 11 312 / Invention Specification (Supplement) / 92-12 / 92126607 200416045 amine IIIB, nerve Tamine I II A, Neuramin IV, Fit Intercellular Lipid I (above manufactured by DEGUSSA), Neuramin II (made by Sederma), Neuramin TIC-01 (by Takasago Fragrance) . In the general formula (3), R 15 is a straight or branched saturated or unsaturated hydrocarbon group having a carbon number of 1 4 to 2 2 which may also be substituted by one or more hydroxyl groups, particularly a linear alkyl group. Better. Among them, pentadecyl and trihydroxypentadecyl are more preferred. R | 6 is preferably a linear alkyl group or alkoxy group having 8 to 24 carbon atoms. Among them, nonyl and hexadecyloxy are more preferred. Regarding the combination of R 16 and R 17, when R 17 is a hydrogen atom or 2-hydroxyethyl, R 16 is preferably a linear alkoxy group, and when R 17 is 2, 3 -dihydroxypropyl, R 11 is A linear alkyl group is preferred. Regarding the combination of Y and R17, when R17 is a hydrogen atom or 2-hydroxyethyl, Y is preferably a hydroxyl group, and when R17 is a 2,3-dihydroxypropyl group, Y is preferably a hydrogen atom. Specific examples of the amidine compounds represented by the general formula (3) include compounds represented by the following formulae (5), (6), and (7).

式(5)Equation (5)

31W發明說明書(補件)/92-12/92126607 12 200416045 又,式(3)之醯胺化合物,可以日本專利特開昭 6 2 - 2 2 8 0 4 8號公報等中所記述的方法製造;例如,將由縮 水甘油基醚與乙醇胺所得之反應物進行醯化,然後,使酯 基進行選擇性的水解的方法等。 其中,以由通式(5 )所表示之縫胺化合物為佳,其係以 商品名 Sofcare ceramide SL_E(N-3-六癸氧基-2-經丙 基)-N - 2 -羥乙基六癸醯胺,花王(股))而販售於市面上。 作為以通式(4 )所表示之醯胺化合物的R 18,以亦可由選 自羥基及碳數 1〜6的烷氧基的1〜3個基取代之碳數1〜2 2 的直鏈或分枝鏈的烷基為佳,亦可以羥基與烷氧基同時取 代。 較佳者為例如··碳數1〜1 8的烷基、碳數1〜1 8的單或二 羥烷基、經碳數1〜6的烷氧基取代之碳數1〜1 8的烷基、及 經羥基與碳數1〜6的烷氧基取代之碳數1〜1 8的烷基。尤其 更佳者為,碳數1〜1 8的烷基、碳數2〜1 2的單或二羥烷基、 經碳數1〜6的烷氧基取代之碳數2〜1 2的烷基、及經羥基與 碳數1〜6的烷氧基取代之碳數2〜1 2的烷基。其中,作為 R18,以2 -羥乙基、甲基、月桂基、2 -甲氧基乙基為更佳。 R 19以碳數1〜1 2的直鏈或分枝鏈的伸烷基為佳,而以碳 數2〜6的直鏈或分枝鏈的伸烷基為更佳。其中,尤以伸乙 基及三亞甲基為更佳。 R2 °以碳數2〜3 4的直鏈或分枝鏈的二價烴基為佳,而以 碳數2〜3 4的直鏈或分枝鏈的伸烷基或有1〜4個雙鍵的伸鏈 烯基為更佳,尤以碳數2〜2 4的直鏈或分枝鏈的伸烷基或有 13 312/發明說明書(補件)/92-12/92126607 200416045 卜4個雙鍵的伸鏈烯基為特佳。其中,較佳者為:7,1 2 -二 曱基伸十八碳基、7,1 2 -二曱基-7,1卜伸十八碳二烯基、伸 十八碳基、伸辛基、伸癸基、伸十一碳基、伸十三碳基。 作為以通式(4 )所表示之醯胺化合物,以 R 18、R 19、R21 分別為上述之較佳的範圍的基所組合而成之化合物為佳。 通式(4 )之醯胺化合物可例如於國際公開第0 0 / 6 1 0 9 7號 公報等中所記述的方法般,經由使對應的二羧酸或其反應 性衍生物(酯、酸鹵化物、酸酐等)與胺進行縮合而有效率 地製得。 作為本發明之水中油型乳化組成物中所用之兩親媒性 脂質,尤其以屬於通式(4 )所表示之醯胺化合物之以下述式 (8 )〜式(1 4 )所表示之化合物為特佳。 Ησ31W Invention Specification (Supplement) / 92-12 / 92126607 12 200416045 In addition, the amidine compound of formula (3) can be produced by a method described in Japanese Patent Laid-Open No. 6 2-2 2 8 0 4 8 For example, a method of subjecting a reactant obtained from a glycidyl ether and ethanolamine to halogenation, and then selectively hydrolyzing an ester group. Among them, it is preferred that the stilbene amine compound represented by the general formula (5) is a trade name Sofcare ceramide SL_E (N-3-hexadecyloxy-2-propyl) -N-2 -hydroxyethyl Hexadecanylamine, Kao (stock)) are sold on the market. As R 18 of the amidine compound represented by the general formula (4), a straight chain of 1 to 2 2 carbon atoms which may be substituted by 1 to 3 groups selected from a hydroxyl group and an alkoxy group of 1 to 6 carbon atoms. Or a branched alkyl group is preferable, and a hydroxyl group and an alkoxy group may be substituted simultaneously. Preferred are, for example, an alkyl group having 1 to 18 carbon atoms, a mono- or dihydroxyalkyl group having 1 to 18 carbon atoms, and an alkyl group having 1 to 18 carbon atoms substituted with an alkoxy group having 1 to 6 carbon atoms. Alkyl groups, and alkyl groups having 1 to 18 carbon atoms substituted by a hydroxyl group and an alkoxy group having 1 to 6 carbon atoms. Especially preferred are alkyl groups having 1 to 18 carbons, mono or dihydroxyalkyl groups having 2 to 12 carbons, and alkane groups having 2 to 12 carbons substituted with alkoxy groups having 1 to 6 carbon atoms. And an alkyl group having 2 to 12 carbon atoms substituted with a hydroxyl group and an alkoxy group having 1 to 6 carbon atoms. Among them, R18 is more preferably 2-hydroxyethyl, methyl, lauryl, or 2-methoxyethyl. R 19 is preferably a linear or branched alkylene group having 1 to 12 carbon atoms, and more preferably a linear or branched alkylene group having 2 to 6 carbon atoms. Among them, ethylene and trimethylene are more preferable. R2 ° is preferably a straight or branched divalent hydrocarbon group having 2 to 3 carbons, and a straight or branched alkylene group having 2 to 3 4 carbons or 1 to 4 double bonds Alkenyl is more preferred, especially straight or branched alkylene with 2 to 2 carbon atoms or 13 312 / Invention Specification (Supplement) / 92-12 / 92126607 200416045 4 double Bonded alkenyl groups are particularly preferred. Among them, preferred are: 7,1 2 -diamidyl octadecyl, 7,1 2 -diamidyl-7,1 octadecadienyl, octadecyl, octyl , Decyl, eleven carbon, and thirteen carbon. As the amido compound represented by the general formula (4), a compound in which R 18, R 19, and R 21 are each a group in the above-mentioned preferable range is preferable. The amidine compound of the general formula (4) can be prepared, for example, by a method described in International Publication No. 0 0/6 1 0 97 and the like, by passing a corresponding dicarboxylic acid or a reactive derivative thereof (ester, acid) Halides, anhydrides, etc.) are efficiently produced by condensation with amines. As the amphipathic lipid used in the oil-in-water emulsion composition of the present invention, in particular, compounds represented by the following formulae (8) to (1 4) which belong to the amidine compound represented by the general formula (4) Especially good. Ησ

、〜OH, ~ OH

O CH3 Η 、〜〇Η 式(9)O CH3 Η, ~ 〇Η Formula (9)

H CH3 〇 HOH CH3 〇 HO

.OH.OH

HOHO

式(1 1(1 1

O CH3 H 式(1 2) ]4 3 H CH3 〇 3 ] 2/發明說明書(補件)/92- ] 2/92 ] 26607 200416045 〇 ch3 Η ηΓ Η 式(1 3) c12h25〇vN^^y^^^〇;Na〇Ci2H25 12 25 H CH3 〇 CH 〇〜〜〇CH3 式(1 4 ) 3 H CH3 Ο (B )兩親媒性脂質的含有量,為能充分發揮對皮膚 障作用與保濕作用,以在水中油型乳化組成物之總組 占0 · 1質量%以上為佳,若就與保存安定性間的均衡性 量,則以在總組成中占0 . 1〜2 0質量%為更佳,尤以0 . 質量%為特佳。 又,陽離子型界面活性劑(A )與兩親媒性脂質(B )的 比(A ·· B ),就對皮膚的效果之發揮及較佳的液晶構造 成的觀點考量,以1 0 : 1〜1 : 2 0為佳,而以1 0 : 1〜1 為更佳。 本發明中,選自2價及3價醇的醇類(C ),於調配 化化妝材料中時,可使前述之陽離子型界面活性劑溶 分散。陽離子型界面活性劑(A )在與醇類(C )混合之後 由與含有兩親媒性脂質(B)的油性成分混合,即使陽離 面活性劑為低濃度亦可形成較佳的液晶構造體。 作為這樣的醇類(C),可舉出:乙二醇、聚乙二醇( 分子量200〜400)、丙二醇、二丙二醇、1,3 -丁二醇、甘 聚甘油(聚合度2〜5 )等。其中尤以甘油、乙二醇為更&gt; 醇類(C )的含有量,就具有良好的使用感、可形成 的液晶構造體、可得到安定的乳化物之觀點來考量, 中油型乳化組成物之總組成中以定為5〜4 0質量%為佳 312/發明說明書(補件)/92-12/92126607 之屏 成中 來考 卜1 0 質量 之形 :10 至乳 解· ,經 子界 平均 油、 較佳 於水 ,尤 15 200416045 以定為5〜2 0質量%為更佳。 於本發明之水中油型乳化組成物中,於兩親媒性脂質(Β ) 之外,亦可含有一般化妝材料中所使用之液狀、半固體或 固體狀之合成及天然來源之油性成分,例如烴油、酯油、 醚油、聚石夕氧油、氟油等。 作為液狀油,可舉出例如:荷荷葩油等之植物油;液狀 羊毛脂等之動物油;流動石蠟、角鯊烷等之烴油;蘋果酸 二異硬脂酸酯、乳酸辛基十二烷酯、異壬酸異十三烷酯、 異硬脂酸異丙酯、肉菫蔻酸辛基十二烷酯、二癸酸新戊二 醇酯等之酯油;甘油衍生物、氨基酸衍生物、二曱基聚矽 氧烷、二曱基環聚矽氧烷、甲基苯基聚矽氧烷、甲基氫化 二烯聚矽氧烷、高級醇改質有機聚矽氧烷等之聚矽氧油; 氟化聚醚、過氟烷基醚聚矽氧等之氟油等。 作為固體或半固體之油性成分,可舉出例如:荷荷葩蠟 等之植物性蠟;甘油單硬脂基醚、甘油單鯨蠟基醚等之烷 基甘油醚;凡士林、羊毛脂、純地蠟、微結晶蠟、巴西棕 摘虫鼠(c a r n a u b a wax)、小濁樹虫鼠(c a n d e 1 i 1 1 a w a x )等之虫鼠 類。 此等油性成分之含有量,通常於總組成物中為 Ο . 1〜3 Ο 質量%,而以1〜2 0質量%為佳。 又,於以防紫外線(U V )化妝材料為目的之乳化組成物 中,可適當地含有稱為UV吸收劑或UV分散劑之UV防護 劑。作為UV吸收劑,可使用對甲氧基肉桂酸系、二苯基酮 系、4 -咪唑丙烯酸系、對胺‘基苯曱酸系、水楊酸系、苯醯 16 312/發明說明書(補件)/92-12/92126607 200416045 甲烷系、三嗉系、鄰胺基苯甲酸系等之化合物,作為 分散劑,可使用二氧化鈦、氧化鋅、氧化鐵等之粉體。 此種U V防護劑的含有量,通常於總組成物中為1〜4 0 量%,而以1〜2 0質量%為佳。 此防 UV化妝材料,為使其耐水性高、不易因汗或水 而脫落,係製成水中油型乳化組成物,並有良好的UV防 效果的持續性。 本發明中用以形成水中油型乳化組成物的水相連續 的水(D )之含有量,於總組成中通常為1 0〜9 0質量%,而 4 0〜9 0質量%為佳。作為水以外的水相成分,亦可在不損 本發明之目的及效果之質與量的範圍内配合以前述醇類 外之一般化妝材料中可使用的水溶性成分,例如:乙醇、 種水溶性藥效劑、抗氧化劑、防腐劑、殺菌劑、鹽類、 基酸、糖類、螯合劑、增黏劑、色素、香料等。 本發明之水中油型乳化組成物,尤以經由下述步驟製 為佳,其為:將陽離子型界面活性劑(A )的至少1種添加 醇類(C)的至少1種中之第一步驟;將另外進行混合成之 有兩親媒性脂質(B )的油性分散相,添加到上述第一步驟 得之混合物中之第二步驟;與對上述第二步驟所得之混 物添加水性介質之第三步驟。 將對甘油等之醇類加入陽離子型界面活性劑所得之 合物與含有兩親媒性脂質之油相混合之後,添加到含有 類以外的水性成分之水相中進行乳化,藉此,可不使含 兩親媒性脂質之油相發生分離地作成安定的乳化狀態。 312/發明說明書(補件)/92-12/92126607 UV 質 等 護 相 以 及 以 各 氨 造 到 含 所 合 混 醇 有 17 200416045 亦即,藉由以上述之順序調製乳化組成物,陽離子 面活性劑與兩親媒性脂質會在多元醇中形成液晶構造 得到之增黏構造體,對於油滴的合一、乳霜化可成為 的狀態。此處,於將兩親媒性脂質(B)與油性成分等之 成分混合之時,為了提高溶解或分散性,需要時亦可 加溫。 本發明之水中油型乳化組成物,係呈現乳液狀乃至 霜狀的外觀,於25°C的黏度以1,000〜100,000mPa· s 度為佳。又,黏度可用B型黏度計測定。 本發明之水中油型乳化組成物,作為外用藥劑或化 料是有用的,尤其是作為化妝材料甚為有用,依其用 可作成乳液、凝膠、乳霜、防紫外線化妝材料、喷氣 珠等之任意的劑型。 (實施例) 茲經由下述之實施例,進一步說明本發明,並明示 發明之實施形態。惟,所提示之實施例只用來作為例 目的,不可解釋成用以限定本發明者。又,表中之註 如下述: 木1:花王(股),Sofcare ceram i de SL-E 氺2 : Goldschmidt 公司,Varisoft TA-100 氺3 : Goldschmidt 公司,Varisoft BT-85 *4 :花王(股),EXCEPARL艾吉西巴爾DG-MI 木5:信越化學(股),SILICONE KF-96A(10cs) (評價項目) 312/發明說明書(補件)/92-12/92126607 型界 ,而 安定 其他 進行 於乳 的程 妝材 途, 式泡 出本 證的 解係 18 200416045 (1 )增黏構造體的形成之有無 將少量的乳化組成物置於載玻片上,其上覆以 後,以偏光顯微鏡(Nikon公司,ECLIPSE E600 光學異向性的確認。 (2 )外觀 乳化組成物剛調製完成的狀態為均一的乳化 況,判斷為「良好」,又,可看出有分離的情況, 「分離」。然後,將乳化組成物約40g裝入50mL 璃瓶中,以5 0 °C及5 °C的恆溫槽進行1個月的保 其乳化狀態依下述的基準以目視觀察。 〈評價基準〉 〇:無法看到分離 △:可看到有若干的分離 X :可看到明顯的分離(於成品之特性上有問題丨 (3 )黏度測定 將乳化組成物約4 0 g置入5 0 m L的廣口玻璃瓶 2 5 °C的水浴中,將瓶蓋以外的部分全部浸入,於 保持2小時。經過2小時後,立刻將玻璃瓶自水 用B型黏度計(型式B8R,東京計器(股)公司製) 測定,求出在2 5 °C之黏度。 (4)pH測定 將乳化組成物置入有蓋的玻璃瓶中,在保持於 浴中浸潰 2 小時,將玻璃瓶自水浴取出之後, (H0RIBA 公司製,pH METER F-22)測定。 312/發明說明書(補件)/92-12/92126607 盖玻片之 P0L)進行 狀態之情 則判斷為 的廣口玻 存後,祝 勺程度) ,保持於 該狀態下 浴取出, 進行黏度 2 5 °C的水 以 p Η計 19 200416045 (實施例1及比較例1 ) 依照表1之組成,以下述的順序製造水中油型乳化組成 物,並進行評價。將結果一併示於表1中。 〈製造方法〉 使成分(1 )及(2 )於 8 0 °C下均一地溶解·分散,得到油 相。另外將成分(3 )或(4 )的陽離子型界面活性劑添加到成 分(5 )的醇類中,於 8 0 °C下均一地溶解,並於維持溫度的 狀態下,將上述油相加入。再加入成分(6 )的水,一邊保持 於8 0 °C,一邊用均質機進行乳化,得到乳化物。再於攪拌 下使其冷卻到室溫(2 5 °C )。 表1 實施例1及比較例1 成分 實施例1 比較例1 油相 B 1 式(2 )醯胺化合物* 1 1. 0 1. 0 2 角鯊烷 6. 0 6. 0 A 3 氣化二硬脂基二甲基銨*2 0. 8 4 氣化硬脂基三甲基銨*3 0. 8 水相 C 5 甘油 10. 0 10. 0 6 純水 餘量 餘量 合計 100.0 100.0 評價 增黏性構造體的形成之有無(以偏光顯微鏡 確認) 有 無 水浴浸潰2小時後的黏度(mPa · s) 80 0 0 1 4 0 0 0 水浴浸潰時後的pH 5. 0 4.9 外觀(水浴浸漬2小時後) 良好 良好 (5 0 °C ,1 個月) 〇 Δ (5 °C ,1 個月) 〇 Δ (實施例2 )乳液 依照表2的組成,以與實施例1同樣的順序調製乳液。 亦即,使成分(1 )〜(4 )於 8 0 °C下均一地溶解·分散,得到 油相。再將成分(5 )的陽離子型界面活性劑添加到成分(6 ) 的醇類中,於 8 0 °C下均一地溶解,並於維持溫度的狀態 20 312/發明說明書(補件)/92-12/92126607 200416045 下,將上述油相加入。另外將由成分(7 )〜(8 )於 8 0 °C下混 合所得之水相添加到上述得到之油相中,一邊保持於8 0 °C 一邊用均質機進行乳化,得到乳化物。再於攪拌下使其冷 卻到室溫(2 5 °C )。 得到之乳液的黏度為8000mPa· s,pH為5.4。又,於5 °C及5 0 °C下保存1個月後的乳化安定性良好。 表2 乳液 成分 質量% 油相 1 式(2)之醯胺化合物*1 1.0 2 硬脂醇 1. 0 3 異硬脂基十四烧基甘油*4 6.0 4 二甲基聚矽氧烷*5 1.0 5 氣化二硬脂基二甲基銨*2 0.5 水相 6 甘油 7. 5 7 對羥基苯曱酸曱酯 0.2 8 純水 餘量 合計 100.0 (實施例3 )乳霜 依照表3的組成,以與實施例2同樣的順序調製乳霜。 得到之乳霜的黏度為50000mPa· s,pH為5.2。又,於 5 °C及5 0 °C下保存1個月後的乳化安定性良好。 表3 乳霜 成分 質量! 油相 1 式(2)之醯胺化合物*1 3.0 2 山榆醇 3.0 3 二癸酸新戊二醇 6. 0 4 二曱基聚矽氧烷*5 3. 0 5 氣化二硬脂基二甲基銨* 2 0. 8 水相 6 甘油 10. 0 7 對羥基苯曱酸曱酯 0.1 8 純水 餘量 合計 100.0 21 312/發明說明書(補件)/92-12/92126607 200416045 (實施例4) UV乳液 依照表4的組成,以與實施例1同樣的順序調製UV乳 液。亦即,使成分(1 )〜(5 )於 8 0 °C下均一地溶解·分散, 得到油相。再將成分(7 )的陽離子型界面活性劑添加到成分 (8 )的醇類中,於 8 0 °C下均一地溶解,並於維持溫度的狀 態下,將上述油相加入。另外將由成分(6 )及(9 )〜(1 0 )於 8 0 °C下混合所得之水相添加到上述得到之油相中,一邊保 持於8 0 °C,一邊用均質機進行乳化,得到乳化物。再於攪 拌下使其冷卻到室溫(2 5 °C )。 得到之U V乳液的黏度為1 2 0 0 0 m P a · s,p Η為6 . 2。又, 於5 °C及5 0 °C下保存1個月後的乳化安定性良好。 實際試驗之結果,UV防護性能之持續性亦良好。 表4 UV乳液 成分 質量!¾ 油相 1 式(2)之醯胺化合物*1 1.0 2 山榆醇 1. 0 3 異硬脂基十四烷基甘油*4 6. 0 4 對甲氧基肉桂酸2-乙基己基酯 3.0 5 二甲基聚矽氧烷*5 7. 0 6 二氧化鈦 3.0 7 氣化二硬脂基二甲基銨* 2 0.5 水相 8 甘油 7. 5 9 對羥基苯曱酸甲酯 0. 1 10 純水 餘量 合計 100.0 (實施例5) UV乳霜 依照表5的組成,以與實施例1同樣的順序調製UV乳 霜。亦即,使成分(1 )〜(7 )於 8 0 °C下均一地溶解·分散, 得到油相。再將成分(8 )的陽離子型界面活性劑添加到成分 22 312/發明說明書(補件)/92-12/92126607 200416045 (9 )的醇類中,於 8 0 °C下均一地溶解,並於維持溫度的狀 態下,將上述油相加入。另外將由成分(1 0 )〜(1 1 )於 8 0 °C 下混合所得之水相添加到上述得到之油相中,一邊保持於 8 0 °C ,一邊用均質機進行乳化,得到乳化物。再於攪拌下 使其冷卻到室溫(2 5 °C )。 得到之乳霜的黏度為44000mPa· s,pH為4.9。又,於 5 °C及5 0 °C下保存1個月後的乳化安定性良好。 實際試驗之結果,UV防護性能之持續性亦良好。 表5 UV乳霜 成分 質量% 油相 1 式(2)之醯胺化合物*1 2.0 2 山榆醇 2. 0 3 鯊肝醇 0. 5 4 4_第四丁基4'-曱氧基苯醯基曱烷 0.5 5 對曱氧基肉桂酸2 -乙基己基酯 5.0 6 異壬酸異十三烷基酯 3.0 7 二甲基聚矽氧烷*5 3. 0 8 氣化二硬脂基二甲基銨*2 1. 0 水相 9 甘油 15.0 10 對羥基苯曱酸曱酯 0. 1 11 純水 餘量 合計 100.0 (實施例6〜8 ) 乳液或乳霜 依照表6的組成,以與實施例2同樣的順序調製乳液或 乳霜。亦即,使成分(1 )〜(5 )於8 0 °C下均一地溶解·分散, 得到油相。再將成分(6 )的陽離子型界面活性劑添加到成分 (7 )的醇類中,於 8 0 °C下均一地溶解,並於維持溫度的狀 態下,將上述油相加入。另外將由成分(8 )〜(1 0 )於8 0 °C下 混合所得之水相添加到上述得到之油相中,一邊保持於8 0 °C ,一邊用均質機進行乳化,得到乳化物。再於攪拌下使 23 312/發明說明書(補件)/92-12/92126607 200416045 其冷卻到室溫(2 5 °C )。 得到之乳液或乳霜的黏度及pH —併示於表6中。任一 者之乳化狀態皆為良好,又,於5 °C及5 0 °C下保存1個月 後的乳化安定性亦良好。 表6 乳液或乳霜 實施例 6 7 8 油相 1 式(2 )之醯胺化合物* 1 0. 2 0. 2 1.0 2 山榆醇 0.4 0.4 2.0 3 鯊肝醇 0. 2 0. 2 1.0 4 角鯊烷 1. 5 1.5 3. 0 5 二甲基聚矽氧烷*5 - - 3.0 6 氣化二硬脂基二甲基銨木2 0. 1 0. 2 0. 8 水相 7 甘油 7.5 7. 5 10. 0 8 對羥基苯曱酸甲酯 0.3 0. 3 0. 3 9 香料 適量 適量 適量 10 純水 餘量 餘量 餘量 評價 黏度(mPa.s) 4 0 0 0 7500 3 5 0 0 0 pH 5.0 4.8 5.2 (產業上之可利用性) 如上所述,含有神經醯胺等之兩親媒性脂質的本發明之 水中油型乳化組成物,由於會形成於靜置時液晶構造安定 性、而塗佈等之使用時崩解性良好之具搖溶性的增黏構造 體,故保存時的乳化安定性優異,使用感亦優異。再者, 由於界面活性劑為低濃度,且為弱酸性,故對皮膚的刺激 性小。因而,本發明之水中油型乳化組成物,其乳化安定 性及使用感優異,且對皮膚的刺激性小,作為外用藥或化 妝材料是有用的,尤其是作為化妝材料甚有用。 又,本發明之製造方法為用以製造方法上述水中油型乳 化組成物的較佳的方法,可以少量的界面活性劑可使兩親 媒性脂質安定地乳化,而且可形成使用感優異之具有搖溶 24 312/發明說明書(補件)/92-12/92126607 200416045 性之增黏構造體。此製造方法即使不特別進行pH調整,亦 可得到弱酸性的乳化組成物,故於生產性方面亦甚有利。 25 312/發明說明書(補件)/92-12/92126607O CH3 H Formula (1 2)] 4 3 H CH3 〇3] 2 / Invention (Supplement) / 92-] 2/92] 26607 200416045 〇ch3 Η ηΓ Η Formula (1 3) c12h25〇vN ^^ y ^^^ 〇; Na〇Ci2H25 12 25 H CH3 〇CH 〇 ~ 〜〇CH3 Formula (1 4) 3 H CH3 〇 (B) amphiphilic lipid content, in order to fully play the role of skin barrier and moisturizing 1 to 2 0% by mass of the total composition of the oil-based emulsified composition in water is preferred. If the balance between storage stability and stability is 0.1 to 2% by mass More preferably, 0. mass% is particularly preferred. In addition, the ratio (A ·· B) of the cationic surfactant (A) to the amphiphilic lipid (B) is considered from the viewpoint of exerting the effect on the skin and a better liquid crystal structure. 1 to 1: 2 0 is preferable, and 10: 1 to 1 is more preferable. In the present invention, the alcohols (C) selected from the group consisting of divalent and trivalent alcohols can be used to dissolve and disperse the aforementioned cationic surfactants when formulating in cosmetic materials. The cationic surfactant (A) is mixed with an alcohol (C) and mixed with an oily component containing an amphiphilic lipid (B). Even if the cationic surfactant is low in concentration, a better liquid crystal structure can be formed. body. Examples of such alcohols (C) include ethylene glycol, polyethylene glycol (molecular weight 200 to 400), propylene glycol, dipropylene glycol, 1,3-butanediol, and glycerol (polymerization degree 2 to 5) )Wait. Among them, glycerin and ethylene glycol are particularly preferred. The content of alcohols (C) is considered from the viewpoints of good usability, a liquid crystal structure that can be formed, and stable emulsions. In the total composition of the material, it is better to set it as 5 ~ 40% by mass. 312 / Invention Specification (Supplements) / 92-12 / 92126607 Screen Chengzhong to test the form of 10 mass: 10 to milk solution. The sub-world average oil is better than water, especially 15 200416045 is more preferably set to 5 to 20% by mass. In the oil-in-water emulsion composition of the present invention, in addition to the amphipathic lipid (B), it may contain liquid, semi-solid or solid synthetic and natural-source oily ingredients used in general cosmetic materials. , Such as hydrocarbon oils, ester oils, ether oils, polyoxyl oils, fluorine oils, and the like. Examples of the liquid oil include: vegetable oils such as jojoba oil; animal oils such as liquid lanolin; hydrocarbon oils such as flowing paraffin and squalane; diisostearate malate and octyl lactate Ester oils of dialkyl esters, isododecanoyl isononanoate, isopropyl isostearate, octyldodecyl myristate, neopentyl glycol didecanoate, etc .; glycerol derivatives, amino acid derivatives Polymer, difluorenyl polysiloxane, difluorenyl cyclopolysiloxane, methylphenyl polysiloxane, methylhydrodiene polysiloxane, higher alcohol modified organic polysiloxane, etc. Silicone oil; Fluorinated oils such as fluorinated polyether, perfluoroalkyl ether polysiloxane, etc. Examples of solid or semi-solid oily ingredients include vegetable waxes such as jojoba wax; alkyl glyceryl ethers such as glyceryl monostearyl ether and glyceryl monocetyl ether; petrolatum, lanolin, pure Earth waxes, microcrystalline waxes, carnauba waxes, cande 1 i 1 1 awax, etc. The content of these oily ingredients is usually 0. 1 to 3 0% by mass, and preferably 1 to 20% by mass in the total composition. In addition, the emulsified composition for the purpose of preventing ultraviolet (UV) cosmetic materials may suitably contain a UV protective agent called a UV absorber or a UV dispersant. As the UV absorber, p-methoxycinnamic acid-based, diphenyl ketone-based, 4-imidazole acrylic-based, p-amine'-phenylbenzoic acid-based, salicylic acid-based, phenylhydrazone 16 312 / Invention Specification (Supplementary Pieces) / 92-12 / 92126607 200416045 Methane-based, tertiary-based, o-aminobenzoic acid-based compounds, etc. As the dispersant, powders such as titanium dioxide, zinc oxide, and iron oxide can be used. The content of such a U V protective agent is usually 1 to 40% by mass, and preferably 1 to 20% by mass in the total composition. This UV-resistant cosmetic material is made of an oil-in-water emulsified composition in order to make it highly resistant to water and difficult to fall off due to sweat or water, and has good durability of UV protection effect. The content of continuous water (D) in the water phase for forming an oil-in-water emulsified composition in the present invention is usually 10 to 90% by mass, and preferably 40 to 90% by mass in the total composition. As a water phase component other than water, water-soluble components that can be used in general cosmetic materials other than the aforementioned alcohols, such as ethanol and water-soluble components, can be blended within a range of quality and quantity that does not impair the object and effect of the present invention. Sexual pharmacological agents, antioxidants, preservatives, fungicides, salts, base acids, sugars, chelating agents, thickeners, pigments, flavors, etc. The oil-in-water emulsified composition of the present invention is particularly preferably prepared through the following steps, which is: adding at least one of the cationic surfactant (A) to at least one of the alcohols (C) Step; adding an oily dispersed phase having amphiphilic lipid (B) which is additionally mixed, and adding it to the mixture obtained in the first step; and adding an aqueous medium to the mixture obtained in the second step The third step. A compound obtained by adding a cationic surfactant to an alcohol such as glycerol is mixed with an oil phase containing an amphiphilic lipid, and then added to an aqueous phase containing an aqueous component other than the type to emulsify. The oil phase containing amphiphilic lipids separates into a stable emulsified state. 312 / Instruction of the Invention (Supplement) / 92-12 / 92126607 UV-protective phase, and each ammonia is made to contain the blended alcohol. 17 200416045 That is, by preparing the emulsified composition in the above order, the cationic surface activity The agent and the amphiphilic lipid will form a thickened structure obtained from the liquid crystal structure in the polyhydric alcohol, and can become a state where the oil droplets are unified and frosted. Here, when the amphipathic lipid (B) is mixed with components such as an oily component, in order to improve the solubility or dispersibility, it may be heated if necessary. The oil-in-water emulsion composition of the present invention has an emulsion-like or frost-like appearance, and its viscosity at 25 ° C is preferably 1,000 to 100,000 mPa · s. The viscosity can be measured with a B-type viscometer. The oil-in-water emulsified composition of the present invention is useful as an external medicine or chemical, especially as a cosmetic material. Depending on its use, it can be used as an emulsion, gel, cream, UV-proof cosmetic material, jet beads, etc. Any of the dosage forms. (Examples) The present invention will be further explained by way of the following examples, and the embodiments of the invention will be clearly shown. However, the suggested embodiments are only for the purpose of illustration, and should not be interpreted to limit the inventor. The notes in the table are as follows: Wood 1: Kao (share), Sofcare ceram i de SL-E 氺 2: Goldschmidt company, Varisoft TA-100 氺 3: Goldschmidt company, Varisoft BT-85 * 4: Kao (share ), EXCEPARL DG-MI Wood 5: Shin-Etsu Chemical Co., Ltd., SILICONE KF-96A (10cs) (Evaluation item) 312 / Invention Specification (Supplement) / 92-12 / 92126607 Type boundary, and settle other The process of applying makeup to milk is to extract the solution of this certificate. 18 200416045 (1) Whether the thickened structure is formed. Put a small amount of emulsified composition on a glass slide, and cover it with a polarizing microscope ( Nikon Corporation, ECLIPSE E600 Confirmation of Optical Anisotropy. (2) The appearance of the emulsified composition was uniformly emulsified immediately after the preparation, and it was judged as "good", and it was seen that there was separation, "separation". Then, about 40 g of the emulsified composition was put into a 50-mL glass bottle, and the emulsified state was maintained in a thermostatic bath at 50 ° C and 5 ° C for one month to visually observe the emulsified state according to the following criteria. <Evaluation Criteria> 〇 : No separation can be seen △: Some separation can be seen X : Obvious separation can be seen (there is a problem in the characteristics of the finished product) (3) Viscosity measurement Put about 40 g of the emulsified composition into a 50 ml wide-mouth glass bottle 2 5 ° C water bath, place the bottle Immerse all parts except the cap, and keep it for 2 hours. After 2 hours, measure the glass bottle from water with a B-type viscometer (type B8R, manufactured by Tokyo Keiki Co., Ltd.), and determine the temperature at 2 5 ° C. (4) pH measurement The emulsified composition was placed in a glass bottle with a lid, immersed in a bath for 2 hours, and the glass bottle was taken out of the water bath, and then measured by (Horiba Corporation, pH METER F-22). 312 / Invention Manual (Supplements) / 92-12 / 92126607 (P0L of coverslips) The condition is judged as the wide mouth glass storage, the degree of wish is spooned), keep the bath in this state, and carry out the viscosity 2 5 Water at ° C in terms of p 19 19 200416045 (Example 1 and Comparative Example 1) In accordance with the composition of Table 1, an oil-in-water emulsified composition was produced and evaluated in the following procedure. The results are shown in Table 1 together. <Manufacturing method> The components (1) and (2) were uniformly dissolved and dispersed at 80 ° C to obtain an oil phase. In addition, the cationic surfactant of the component (3) or (4) is added to the alcohol of the component (5), uniformly dissolved at 80 ° C, and the above-mentioned oil phase is added while maintaining the temperature. . Furthermore, water of the component (6) was added and emulsified with a homogenizer while maintaining the temperature at 80 ° C to obtain an emulsified product. Allow to cool to room temperature (25 ° C) with stirring. Table 1 Example 1 and Comparative Example 1 Component Example 1 Comparative Example 1 Oil phase B 1 Formula (2) Amido compound * 1 1. 0 1. 0 2 Squalane 6. 0 6. 0 A 3 Gasification II Stearyl dimethylammonium * 2 0. 8 4 Gasified stearyl trimethylammonium * 3 0.8 Water phase C 5 Glycerin 10. 0 10. 0 6 Pure water balance remaining total 100.0 100.0 Evaluation increase Presence of formation of viscous structures (confirmed with a polarizing microscope) Viscosity after 2 hours of water bath immersion (mPa · s) 80 0 0 1 4 0 0 0 pH 5. 0 4.9 after water bath immersion Appearance (water bath After immersion for 2 hours) Good Good (50 ° C, 1 month) Δ (5 ° C, 1 month) 〇Δ (Example 2) The composition of the emulsion according to Table 2 was the same as that of Example 1 Prepare an emulsion. That is, the components (1) to (4) were uniformly dissolved and dispersed at 80 ° C to obtain an oil phase. Add the cationic surfactant of component (5) to the alcohol of component (6), dissolve uniformly at 80 ° C, and maintain the temperature 20 312 / Explanation of the Invention (Supplement) / 92 -12/92126607 200416045, add the above oil phase. In addition, the water phase obtained by mixing the components (7) to (8) at 80 ° C was added to the oil phase obtained above, and emulsified with a homogenizer while maintaining the temperature at 80 ° C to obtain an emulsion. Allow to cool to room temperature (2 5 ° C) with stirring. The obtained emulsion had a viscosity of 8000 mPa · s and a pH of 5.4. In addition, the emulsion stability after storage at 5 ° C and 50 ° C for one month was good. Table 2 Emulsion component mass% Oil phase 1 Amido compound of formula (2) * 1 1.0 2 Stearyl alcohol 1.03 Isostearyl tetradecyl glycerol * 4 6.0 4 Dimethylpolysiloxane * 5 1.0 5 Gasified distearyldimethylammonium * 2 0.5 Water phase 6 Glycerin 7. 5 7 Ethyl p-hydroxybenzoate 0.2 8 Pure water balance total 100.0 (Example 3) Composition of cream according to Table 3 The cream was prepared in the same procedure as in Example 2. The obtained cream had a viscosity of 50,000 mPa · s and a pH of 5.2. In addition, the emulsion stability after storage at 5 ° C and 50 ° C for one month was good. Table 3 Cream ingredients Quality! Oil phase 1 Amido compound of formula (2) * 1 3.0 2 behenyl alcohol 3.0 3 neopentyl glycol dicaprate 6. 0 4 difluorenyl polysiloxane * 5 3. 0 5 gasified distearyl Dimethylammonium * 2 0. 8 Water phase 6 Glycerin 10. 0 7 Ethyl p-hydroxybenzoate 0.1 8 Total balance of pure water 100.0 21 312 / Invention Specification (Supplement) / 92-12 / 92126607 200416045 (Implementation Example 4) A UV emulsion was prepared according to the composition of Table 4 in the same procedure as in Example 1. That is, the components (1) to (5) were uniformly dissolved and dispersed at 80 ° C to obtain an oil phase. Then, the cationic surfactant of the component (7) was added to the alcohol of the component (8), uniformly dissolved at 80 ° C, and the above-mentioned oil phase was added while maintaining the temperature. In addition, the water phase obtained by mixing the components (6) and (9) to (10) at 80 ° C was added to the oil phase obtained above, and emulsified with a homogenizer while maintaining at 80 ° C. An emulsion was obtained. Allow to cool to room temperature (25 ° C) while stirring. The viscosity of the obtained U V emulsion was 12 000 m P a · s, and p Η was 6.2. In addition, the emulsion stability was good after storage at 5 ° C and 50 ° C for one month. As a result of actual tests, the sustainability of UV protection performance is also good. Table 4 UV emulsion ingredients Quality! ¾ Oil phase 1 Amidine compound of formula (2) * 1 1.0 2 Elm alcohol 1. 0 3 Isostearyl tetradecyl glycerol * 4 6. 0 4 2-Ethylhexyl p-methoxycinnamate 3.0 5 Dimethylpolysiloxane * 5 7. 0 6 Titanium dioxide 3.0 7 Gasified distearyldimethylammonium * 2 0.5 Water phase 8 Glycerin 7. 5 9 Methyl parahydroxybenzoate 0.1 1 10 Total amount of pure water remaining 100.0 (Example 5) UV cream was prepared in the same procedure as in Example 1 according to the composition of Table 5. That is, the components (1) to (7) were uniformly dissolved and dispersed at 80 ° C to obtain an oil phase. Then, the cationic surfactant of the component (8) is added to the alcohol of the component 22 312 / Instruction of the Invention (Supplement) / 92-12 / 92126607 200416045 (9), and uniformly dissolved at 80 ° C, and The above-mentioned oil phase was added while maintaining the temperature. In addition, the water phase obtained by mixing the components (1 0) to (1 1) at 80 ° C was added to the oil phase obtained above, and emulsified with a homogenizer while maintaining at 80 ° C to obtain an emulsified product. . Allow to cool to room temperature (25 ° C) with stirring. The obtained cream had a viscosity of 44000 mPa · s and a pH of 4.9. In addition, the emulsion stability after storage at 5 ° C and 50 ° C for one month was good. As a result of actual tests, the sustainability of UV protection performance is also good. Table 5 Mass% of UV cream ingredients Oil phase 1 Amidine compound of formula (2) * 1 2.0 2 Elm alcohol 2. 0 3 Squalol 0.5 5 4 4_ Fourth butyl 4′-fluorenyloxybenzene Fluorenyl pinane 0.5 5 p-methoxycinnamic acid 2-ethylhexyl ester 5.0 6 isotridecyl isononanoate 3.0 7 dimethylpolysiloxane * 5 3. 0 8 gasified distearyl Dimethylammonium * 2 1. 0 Aqueous phase 9 Glycerin 15.0 10 Ethyl p-hydroxybenzoate 0.1 1 11 Total amount of pure water remaining 100.0 (Examples 6 to 8) The composition of an emulsion or cream according to Table 6 is An emulsion or cream was prepared in the same procedure as in Example 2. That is, the components (1) to (5) were uniformly dissolved and dispersed at 80 ° C to obtain an oil phase. Then, the cationic surfactant of the component (6) is added to the alcohol of the component (7), uniformly dissolved at 80 ° C, and the above-mentioned oil phase is added while maintaining the temperature. In addition, the water phase obtained by mixing the components (8) to (1 0) at 80 ° C was added to the oil phase obtained above, and emulsified with a homogenizer while maintaining the temperature at 80 ° C to obtain an emulsion. Then cool 23 312 / Invention Specification (Supplement) / 92-12 / 92126607 200416045 to room temperature (2 5 ° C) with stirring. The viscosity and pH of the obtained emulsion or cream are shown in Table 6. Emulsification was good in either case, and the emulsion stability after storage at 5 ° C and 50 ° C for one month was also good. Table 6 Emulsion or cream Example 6 7 8 Oil phase 1 Amidamine compound of formula (2) * 1 0.2. 2 1.0 2 behenyl alcohol 0.4 0.4 2.0 3 sharkyl alcohol 0.2 2 0. 2 1.0 4 Squalane 1. 5 1.5 3. 0 5 Dimethylpolysiloxane * 5--3.0 6 Gasified distearyldimethylammonium wood 2 0. 1 0. 2 0. 8 Water phase 7 Glycerin 7.5 7. 5 10. 0 8 Methyl parahydroxybenzoate 0.3 0. 3 0. 3 9 Appropriate amount of fragrance Appropriate amount 10 Appropriate amount of pure water Allowance of remaining margin Evaluation of viscosity (mPa.s) 4 0 0 0 7500 3 5 0 0 0 pH 5.0 4.8 5.2 (Industrial applicability) As described above, the oil-in-water emulsion composition of the present invention containing amphiphilic lipids such as neuraminamide will form a stable liquid crystal structure when it is left to stand. The thickening structure with good disintegrability and good disintegration properties during use such as coating, etc., has excellent emulsification stability during storage and excellent use feeling. Furthermore, since the surfactant is low in concentration and weakly acidic, it has little irritation to the skin. Therefore, the oil-in-water emulsified composition of the present invention is excellent in emulsification stability and feeling of use, and has little irritation to the skin, and is useful as a topical medicine or a cosmetic material, and particularly useful as a cosmetic material. In addition, the manufacturing method of the present invention is a preferred method for manufacturing the above-mentioned oil-in-water emulsified composition. The amphiphilic lipid can be emulsified stably with a small amount of a surfactant, and it can be formed with excellent usability. Shake 24 312 / Invention Manual (Supplement) / 92-12 / 92126607 200416045 Thickening structure. This production method can obtain a weakly acidic emulsified composition even if pH adjustment is not particularly performed, and is therefore very advantageous in terms of productivity. 25 312 / Invention Specification (Supplement) / 92-12 / 92126607

Claims (1)

200416045 拾、申請專利範圍: 1 . 一種水中油型乳化組成物,其特徵在於,係含有:(A) 以下述通式(1 )所表示之 4級銨鹽型陽離子型界面活性劑 之至少1種、(B)兩親媒性脂質、(C) 2價及3價的醇之至 少1種、及(D )水;前述陽離子型界面活性劑(A )的含有量 為0 . 1〜1質量% ;200416045 Scope of patent application: 1. An oil-in-water emulsified composition, characterized in that it contains: (A) at least one of a class 4 ammonium salt type cationic surfactant represented by the following general formula (1) Species, (B) amphipathic lipids, (C) at least one of divalent and trivalent alcohols, and (D) water; the content of the aforementioned cationic surfactant (A) is 0.1 to 1 Mass%; 卜1\ /R3 Λ (式中,R 1及R2為分別獨立之碳數1 6〜2 2之直鏈或分枝鏈 的飽和或不飽和的烴基,R3及R4為分別獨立之碳數1〜3之 烷基,X_為形成鹽之陰離子)。 2 .如申請專利範圍第1項之水中油型乳化組成物,其係 pH為4以上、不滿7者。BU 1 / R3 Λ (wherein R 1 and R 2 are independent or saturated or unsaturated hydrocarbon groups of straight or branched carbon number 16 to 22, and R 3 and R 4 are each independent carbon number 1 ~ 3 alkyl, X_ is an anion forming a salt). 2. The oil-in-water emulsion composition according to item 1 of the scope of patent application, whose pH is 4 or more and less than 7. 3 . —種水中油型乳化組成物之製造方法,其特徵在於, 係將(A )以下述通式(1 )所表示之4級銨鹽型陽離子型界面 活性劑之至少1種與(C ) 2價及3價的醇之至少1種混合之 後,添加入(B )含有兩親媒性脂質的油相,然後再添加水性 介質; R1\ /R3 X 式(1 ) (式中,R 1及R 2為分別獨立之碳數1 6〜2 2之直鏈或分枝鏈 26 312/發明說明書(補件)/92-12/92126607 200416045 卜3之 的飽和或不飽和的烴基,R1及R4為分別獨立之破數 烷基,X _為形成鹽之陰離子)。 27 1 12/發明說明書(補件)/92-12/92126607 200416045 柒、指定代表圖: (一) 本案指定代表圖為:第( )圖。 (二) 本代表圖之元件代表符號簡單說明: 無 捌、本案若有化學式時,請揭示最能顯示發明特徵的化學式: 無 4 312/發明說明書(補件)/92-12/921266073. A method for producing an oil-in-water emulsified composition, characterized in that at least one of the fourth-order ammonium salt-type cationic surfactants represented by (A) in the following general formula (1) and (C ) After mixing at least one of the divalent and trivalent alcohols, add (B) the oil phase containing amphiphilic lipids, and then add the aqueous medium; R1 / / R3 X Formula (1) (where R 1 and R 2 are each a straight or branched chain of carbon number 1 6 ~ 2 2 26 312 / Description of the Invention (Supplement) / 92-12 / 92126607 200416045 The saturated or unsaturated hydrocarbon group of R 3, R1 And R4 are independently broken alkyl groups, and X_ is an anion forming a salt). 27 1 12 / Invention Specification (Supplement) / 92-12 / 92126607 200416045 柒. Designated Representative Map: (1) The designated representative map in this case is: (). (II) Brief description of the representative symbols of the components in this representative drawing: None. If there is a chemical formula in this case, please disclose the chemical formula that can best show the characteristics of the invention: None 4 312 / Invention Specification (Supplement) / 92-12 / 92126607
TW92126607A 2002-12-27 2003-09-26 Oil-in-water emulsion composition and manufacturing method thereof TW200416045A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002381046 2002-12-27

Publications (2)

Publication Number Publication Date
TW200416045A true TW200416045A (en) 2004-09-01
TWI342220B TWI342220B (en) 2011-05-21

Family

ID=34260225

Family Applications (1)

Application Number Title Priority Date Filing Date
TW92126607A TW200416045A (en) 2002-12-27 2003-09-26 Oil-in-water emulsion composition and manufacturing method thereof

Country Status (2)

Country Link
CN (1) CN100369600C (en)
TW (1) TW200416045A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4719575B2 (en) * 2006-01-13 2011-07-06 花王株式会社 Hair cosmetic and method for producing the same
CN102727392A (en) * 2011-03-31 2012-10-17 花王株式会社 Emulsified composition
KR102485259B1 (en) * 2018-03-27 2023-01-06 (주)아모레퍼시픽 Liquid lipid composite composition for improving hair condition
CN112680293B (en) * 2019-10-18 2022-07-08 中国石油化工股份有限公司 Emulsifier, preparation method and application thereof, and method for emulsifying butter in alkaline washing tower

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389418A (en) * 1981-02-25 1983-06-21 S. C. Johnson & Son, Inc. Skin care composition
US5019376A (en) * 1989-03-13 1991-05-28 S. C. Johnson & Son, Inc. Sparkling pearlescent personal care compositions
WO1990010429A1 (en) * 1989-03-13 1990-09-20 S.C. Johnson & Son, Inc. Sparkling pearlescent personal care compositions
JP3333884B2 (en) * 1990-04-27 2002-10-15 ライオン株式会社 Method for producing oil-in-water emulsion
CN1087812A (en) * 1992-10-09 1994-06-15 花王株式会社 Toiletry composition for hair care
JPH07187967A (en) * 1993-12-28 1995-07-25 Kao Corp Hair cleansing agent
JP2000355519A (en) * 1999-06-14 2000-12-26 Lion Corp Production of emulsified cosmetic
JP3715223B2 (en) * 2000-08-04 2005-11-09 花王株式会社 Method for producing oil-in-water emulsion composition

Also Published As

Publication number Publication date
TWI342220B (en) 2011-05-21
CN1511512A (en) 2004-07-14
CN100369600C (en) 2008-02-20

Similar Documents

Publication Publication Date Title
JP4040527B2 (en) Lipid composition and external preparation for skin containing the same
JP5326028B2 (en) Emulsified composition
JP6377381B2 (en) Liposome composition
JP6136043B1 (en) Ripple phase-containing composition, α-gel-forming composition, and external composition for skin and α-gel composition using the same
JP5517511B2 (en) Manufacturing method for cosmetics
JP5342736B2 (en) Oil-in-water emulsion and method for producing the same
BR102015024622B1 (en) antiperspirant compositions
JP2010174012A (en) Personal care sunscreen composition having reduced eye irritation
JP2006036763A (en) Water-in-oil emulsion composition
TWI516278B (en) Water-in-oil type emulsifying cosmetic
EP2174646B1 (en) Reverse vesicle
JP3902174B2 (en) Method for producing oil-in-water emulsion composition
TW201002356A (en) Hair cosmetic
JP2001348320A (en) Lipid composition having liquid crystal structure
JP2005145877A (en) Oil-in-water type emulsified composition
KR101136705B1 (en) Water-in-oil emulsified composition
JP2001048730A (en) Cosmetic
BR112020019017B1 (en) COMPOSITION COMPRISING DIHYDROAVENANTRAMIDE AND POLYALKYLENEGLYCOL DERIVATIVE(S), USE THEREOF AND DERMATOLOGICAL AND/OR COSMETIC PREPARATION TO IMPROVE OR PREVENT UNWANTED SKIN CONDITIONS
JP2006273807A (en) Cosmetic
TW200416045A (en) Oil-in-water emulsion composition and manufacturing method thereof
JP4188149B2 (en) Skin preparation
JP4284236B2 (en) Oil-in-water emulsified cosmetic
JP4188150B2 (en) Skin preparation
JP5064659B2 (en) Pearl agent composition and cosmetics containing the same
JP2010013404A (en) Hair cosmetic

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees